• .

    The JASH 2018 Conference ends with resounding success

  • .

    MakSPH launches Project to Enhance Data Analysis Capacity and Use in East and Southern Africa

  • .

    Infrastructural Expansion of the Makerere University School of Public Health

loading...

Principal Investigator: Dr Victoria Nankabirwa

Funder: Globvac Research Council of Norway

Dr Nankabirwa won a young investigator award to conduct a randomized controlled trial examining the effect of umbilical cord cleansing  with 4% chlorhrxidine, an antiseptic, on omphalitis, septicaemia and neonatal mortality.

Annually, nearly all the estimated worldwide 2.7 million neonatal deaths occur in low and middle-income countries. Infections including those affecting the umbilical cord (omphalitis), are a significant factor in approximately a third of these deaths. In fact, the odds of all-cause mortality are 46% higher among neonates with omphalitis than in those without.

Five large randomized controlled trials in Asia and Sub-Saharan Africa (SSA) have examined the effect of multiple cord stump applications with 4% Chlorhexidine (CHX) for at least 7 days on the risk of omphalitis and neonatal death. These studies, all community-based, show that multiple CHX applications reduced the risk of omphalitis.

Of these trials, only one study from South Asia (the Bangladeshi Study) and none from Africa examined the effect of a single application of CHX as soon as possible after birth. In this Bangladeshi trial, CHX led to a reduction in the risk of mild to moderate omphalitis and neonatal death. It is important in the African setting to explore the effect of a single application among health-facility births. A sinlge application is programmatically much easier to implement than daily applications for 7 days.

The Ugandan CHX study compares umbilical cord cleansing with a single application of 4% CHX at birth and thereafter dry cord care among Ugandan babies born in health facilities that ate at the risk of omphalitis and severe neonatal illness. The CHX study is a facility-based, individually randomized controlled trial that will be conducted among 4760 newborns in Uganda. The primary outcomes are severe illness and omphalitis during the neonatal period. Analysis will be by intention-to-treat.

This study will provide novel evidence from a Sub-Saharan African setting, of the effect of umbilical cord cleansing with a single application of 4% CHX at birth and identify modifiable risk factors for omphalitis.

MakSPH Tweets

Selective Records® SelectiveRecord Selective Records®

RT @billbekunda: #AlcoholPolicy is directed at reducing prevalence of #alcohol related problems thereby promoting the #health of the commun…

2 hours, 59 minutes ago Reply Retweet Favorite
Genisis USA® CalibreGenisis Genisis USA®

RT @billbekunda: #AlcoholPolicy is directed at reducing prevalence of #alcohol related problems thereby promoting the #health of the commun…

3 hours, 13 minutes ago Reply Retweet Favorite
Robert Ssekubugu RSsekubugu Robert Ssekubugu

RT @metsprogrammeug: To being a greater Contribution Congratulations @willy_bazeyo !!! @MakSPH @MakerereU @Kanandra26 @jompango @shirl_el @…

3 hours, 44 minutes ago Reply Retweet Favorite
Calibre▲Clothing™ CalibreClothing Calibre▲Clothing™

RT @billbekunda: #AlcoholPolicy is directed at reducing prevalence of #alcohol related problems thereby promoting the #health of the commun…

4 hours, 22 minutes ago Reply Retweet Favorite

Back to top